Burning Rock Biotech Limited Sponsored ADR

BNR Healthcare Diagnostics & Research

Burning Rock Biotech Limited Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $77.2 million, up 9.18% from fiscal 2024. In the quarter to June 2026, revenue fell 4.22%, EPS fell 98.4%, free cash flow grew 46.0% and total debt fell 5.02%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years; insiders bought in the last twelve months.

12.69 2.91 −18.65%
Market cap
$137.1M
P/E
0.0×
Fwd P/E
11.1×
Dividend yield
—
F-score
5/9
Altman Z
−2.95
Beneish M
−2.47
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+8 more quarters

P/S ratio
12.35 22.79 2.78 1.26
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(270.14) (399.44) 67.70 41.55
P/B ratio
12.41 22.66 2.80 1.21
Price to Tangible BV
12.41 22.67 2.80 1.21
EV/Sales
11.52 21.97 1.89 0.41
EV/EBITDA
0.00 0.00 0.00 0.00
EV/Operating CF
(384.18) (322.44) (35.81) (7.47)
EV/FCF
(57.87) (93.43) (8.83) (1.35)
Quick Ratio
2.72 2.67 2.63 2.77
Current Ratio
3.05 3.05 2.99 3.14
Net Debt/EBITDA
23.18 22.24 36.47 27.91
Debt/Assets
0.24% 3.78% 0.23% 2.04%
Debt/Equity
0.00 0.06 0.00 0.03
Asset Turnover
0.65 0.64 0.65 0.58
Operating CF/Net income
1.24 1.68 (1.35) (0.95)
Capex/Depreciation
— — (0.20) —
Interest Coverage
(1,326.50) (1,365.50) (939.50) (1,133.50)
Research and Development Expense of Revenue
23.17% 25.53% 27.91% 31.51%
Selling, General and Administrative Expense of Revenue
62.76% 64.20% 59.35% 55.85%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
0.00% 0.00% 0.00% 0.00%
Graham Net Nets
0.07 0.04 0.30 0.72
Graham Number
0.00 0.00 0.00 0.00
Earnings Yield
(6.20%) (3.14%) (2.48%) (15.84%)
Free Cash Flow Yield
(1.61%) (1.03%) (7.71%) (23.81%)
Revenue per Share
0.18 0.15 1.84 1.72
Operating CF per Share
(0.03) (0.04) 0.30 0.21
Capex per Share
0.00 0.00 0.00 0.00
Free Cash Flow per Share
(0.03) (0.04) 0.30 0.21
Cash per Share
0.57 0.62 6.47 6.09
Shareholders Equity per Share
0.67 0.71 7.20 7.17
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
0.67 0.71 7.20 7.17
Free Cash Flow
(3.36) (4.25) 3.16 2.24
Working Capital
65.80 68.31 70.30 70.83
Capital Expenditures
— — (0.63) —
Net Current Asset Value
60.50 62.29 64.85 66.97
EV/EBIT
0.00 0.00 0.00 0.00
Capex to Sales
0.00 0.00 0.00 0.00
Price to Operating Income
0.00 0.00 0.00 0.00
Other line items
Average Receivables
25.99 22.91 22.54 24.77
Average Payables
3.57 3.78 5.22 4.20
Average Inventory
6.55 8.44 7.76 8.56
Average Assets
112.89 115.99 119.30 127.21
Average Common Equity
76.01 76.83 78.06 84.78

Fold the line items

Columns are period end dates